Condition: Hypophosphatasia · Sponsor: Alexion Pharmaceuticals, Inc.
In this prospective observational sub-study, participants with pediatric-onset hypophosphatasia (HPP) (perinatal/infantile- or juvenile-onset) of any age will be followed for a minimum of 5 years at sites in the United States and potentially 1 or 2 other countries.
This description comes directly from the study's public registry record.
Alexion Pharmaceuticals, Inc. (Sponsor) · 1-855-752-2356 · clinicaltrials@alexion.com
Always discuss trial participation with your own doctor first.
| Clinical Trial Site | Hartford, Connecticut, United States | Recruiting |
| Clinical Trial Site | Chicago, Illinois, United States | Recruiting |
| Clinical Trial Site | Boston, Massachusetts, United States | Recruiting |
| Clinical Trial Site | Kansas City, Missouri, United States | Recruiting |
| Clinical Trial Site | Mineola, New York, United States | Recruiting |
| Clinical Trial Site | Cincinnati, Ohio, United States | Not Yet Recruiting |
| Clinical Trial Site | Columbus, Ohio, United States | Recruiting |
| Clinical Trial Site | Pittsburgh, Pennsylvania, United States | Not Yet Recruiting |
| Clinical Trial Site | Nashville, Tennessee, United States | Recruiting |
| Clinical Trial Site | Salt Lake City, Utah, United States | Recruiting |
| Clinical Trial Site | Charlottesville, Virginia, United States | Recruiting |
| Clinical Trial Site | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05234567